• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: the treatment of coronary artery disease in cirrhotics needs more thinking-author's reply.

作者信息

Feagins L A

机构信息

Divisions of Gastroenterology and Hepatology, VA North Texas Healthcare System, Dallas, TX, USA.

Division of Digestive and Liver Disease, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Aliment Pharmacol Ther. 2017 Sep;46(6):639. doi: 10.1111/apt.14232.

DOI:10.1111/apt.14232
PMID:28805330
Abstract
摘要

相似文献

1
Letter: the treatment of coronary artery disease in cirrhotics needs more thinking-author's reply.
Aliment Pharmacol Ther. 2017 Sep;46(6):639. doi: 10.1111/apt.14232.
2
Letter: the treatment of coronary artery disease in cirrhotics needs more thinking.信函：肝硬化患者冠状动脉疾病的治疗需要更多思考。
Aliment Pharmacol Ther. 2017 Sep;46(6):638-639. doi: 10.1111/apt.14225.
3
Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy - author's reply.信件：接受冠状动脉支架置入术和抗血小板治疗的肝硬化患者出血——作者回复
Aliment Pharmacol Ther. 2017 Oct;46(7):710. doi: 10.1111/apt.14258.
4
The incidence of arteriosclerotic heart disease among cirrhotics.肝硬化患者中动脉粥样硬化性心脏病的发病率。
Bol Asoc Med P R. 1959 Jun;51:205-11.
5
Coronary artery stents and antiplatelet therapy in patients with cirrhosis.肝硬化患者的冠状动脉支架和抗血小板治疗。
J Clin Gastroenterol. 2012 Apr;46(4):339-44. doi: 10.1097/MCG.0b013e3182371258.
6
Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality.患有冠状动脉疾病且接受心脏支架治疗的肝硬化患者胃肠道出血率较高，但死亡率并未增加。
Aliment Pharmacol Ther. 2017 Jul;46(2):183-192. doi: 10.1111/apt.14121. Epub 2017 May 9.
7
Letter: reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome - author's reply.信函：自身免疫性肝炎/原发性胆汁性肝硬化重叠综合征患者肝纤维化的可逆性及免疫抑制撤减——作者回复
Aliment Pharmacol Ther. 2015 Apr;41(8):794-5. doi: 10.1111/apt.13126.
8
Response to Letter Regarding Article, "Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis: A Registry-Based Matched Case-Control Study".对关于文章《肝硬化患者冠状动脉疾病的患病率及预测：一项基于注册登记的配对病例对照研究》的来信的回复
Circulation. 2015 Jul 14;132(2):e19. doi: 10.1161/CIRCULATIONAHA.115.015220.
9
Letter by Lin et al Regarding Article, "Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis: A Registry-Based Matched Case-Control Study".林等人就“肝硬化患者冠状动脉疾病的患病率及预测：一项基于登记处的匹配病例对照研究”一文所写的信。
Circulation. 2015 Jul 14;132(2):e18. doi: 10.1161/CIRCULATIONAHA.114.013934.
10
[Are thrombopenias of cirrhotics an indication of splenectomy? (author's transl)].
Acta Gastroenterol Belg. 1981 Mar-Apr;44(3-4):203-11.